Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.54
Delayed Data
As of Feb 26
 -0.015 / -2.70%
Today’s Change
0.40
Today|||52-Week Range
0.93
-3.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization10.8K11.5K22.5K25.8K
 
 
 
 
 
 
Operating ExpensesGross Income-10.8K-11.5K-22.5K-25.8K
 
 
 
 
 
General Expenses5.7M6.5M7.2M7.9M
 
 
 
 
 
Research And Development3.5M4.3M4.8M5.4M
 
 
 
 
 
Total Operating Expenses5.7M6.6M7.2M7.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.7M-6.6M-7.2M-7.9M
 
 
 
 
 
Extraordinary Credit0.000.0010.9K--
 
 
Extraordinary Charge-44.6K-280.4K---1.9K
 
 
 
 
Other Expenses-17.00452.9K33.0K253.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-6.4M-7.2M-7.9M
 
 
 
 
 
Net Income-5.7M-6.4M-7.2M-7.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.7M105.1M115.6M123.3M
 
 
 
 
 
Shares To Calculate EPS Diluted102.7M105.1M115.6M123.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.06-$0.06-$0.06
 
 
 
 
 
EPS Diluted-$0.06-$0.06-$0.06-$0.06
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account